Glucocorticoid Receptor Interacts with B-cell Lymphoma 2 for Domineering Aggressiveness of Breast Cancer: An Observational Study
Journal of Current Oncological Trends · 2024
DOI: 10.4103/jcot.jcot_6_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Oncological Trends, 2024. Verfasst von Debanjan Thakur und 8 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Steroid hormone receptors (HRs) such as estrogen receptor/progesterone receptor are routinely used for stratifying breast cancer (BC) patients during endocrine-targeted therapy, except triple-negative BCs which lack these receptors. Thus, probing for alternative steroid HRs with prognostic value in BC is necessary. Glucocorticoid receptor (GR), another steroid HR, associated with prosurvival has been known to be prognostic in breast carcinoma, although studies in the Indian patients’ cohort are scanty. Antiapoptotic protein B-cell lymphoma 2, (Bcl-2) being positively associated with GR, is also known to have a significant influence on BC progression, but its exact role is paradoxical. Aim and Objective: This study aimed to look into the expressional status of GR in the Indian BC patients’ cohort to understand the molecular basis of its association with Bcl-2 to provide a basis for the prognostic value of Bcl-2 and its impact on clinicopathological parameters related to disease progression. This study was conducted in the BC patient cohort ( n = 15) of all molecular subtypes visiting hospital outpatient department. Materials and Methods: In silico data mining, flow cytometry, enzyme-linked immunosorbent assay, immunoblotting, and co-immunoprecipitation were performed to analyze for subsequent observations. Pearson correlation analysis and Chi-squared tests were performed to derive the statistically relevant findings.
Results
GR is co-expressed with Bcl-2 in the concerned cohort, and participates in protein-protein interactions subsequently sustaining its expression and supplementing to aggressiveness of the disease.
Conclusion
GR/Bcl-2 interaction in preliminary findings demanded further extensive research to establish GR and Bcl-2 as promising targets in BC.
Zitieren
APA
Thakur, D., Kar, S., Sengupta, D., Chakrabarti, J., Sen, S., Roy, A., Mahapatra, E., Das, S., & Mukherjee, S. (2024). Glucocorticoid Receptor Interacts with B-cell Lymphoma 2 for Domineering Aggressiveness of Breast Cancer: An Observational Study. Journal of Current Oncological Trends. https://doi.org/10.4103/jcot.jcot_6_23
Vancouver
Thakur D, Kar S, Sengupta D, Chakrabarti J, Sen S, Roy A, et al. Glucocorticoid Receptor Interacts with B-cell Lymphoma 2 for Domineering Aggressiveness of Breast Cancer: An Observational Study. Journal of Current Oncological Trends. 2024. doi:10.4103/jcot.jcot_6_23
BibTeX
@article{Thakur2024,
author = {Thakur, Debanjan and Kar, Shinjini and Sengupta, Debomita and Chakrabarti, Jayanta and Sen, Sagar and Roy, Arindam and Mahapatra, Elizabeth and Das, Salini and Mukherjee, Sutapa},
title = {Glucocorticoid Receptor Interacts with B-cell Lymphoma 2 for Domineering Aggressiveness of Breast Cancer: An Observational Study},
journal = {Journal of Current Oncological Trends},
year = {2024},
doi = {10.4103/jcot.jcot_6_23}
}
EUVIMED